Author: Nathan

Quick Take: H1FY25 ASX:IAG

2025 Insurance Australia Group – Interim Results Summary

https://www.iag.com.au

Overall Tone

Insurance Australia Group’s interim report presents a strong but mixed outlook, with significant profit growth and improved margins. However, a slowdown in gross written premium (GWP) growth, a lower-than-expected dividend, and cautious forward guidance have led to a negative market reaction despite improved profitability.

Financial Performance

Metric 1H25 1H24 % Change
Revenue $9.04bn $8.69bn ▲ 4.0%
Net Profit After Tax (NPAT) $778m $407m ▲ 91.2%
Insurance Profit $957m $614m ▲ 55.9%
Reported Insurance Margin 19.4% 13.7% ▲ 5.7pp
Underlying Insurance Margin 15.1% 13.7% ▲ 1.4pp
Operating Cash Flow $324m $805m ▼ 59.7%
Earnings Per Share (EPS) 32.88c 16.77c ▲ 96.1%
Dividend Per Share 12.0c (60% franked) 10.0c (40% franked) ▲ 20.0%

Key Takeaways

  • Profitability Up, But Revenue Growth Slowing: NPAT nearly doubled, and margins improved, but GWP growth slowed to 6.0%, compared to 12.5% in the prior corresponding period.
  • Dividend Below Expectations: The 12.0c dividend was lower than analyst expectations of 13.9c, contributing to investor disappointment.
  • Premium Growth Concerns: Management indicated GWP growth is likely to be at the lower end of its mid-to-high single-digit forecast range.
  • Cautious Forward Outlook: Slower premium growth and continued investment in digital transformation and claims handling may weigh on future earnings.

Outlook & Guidance

  • FY25 NPAT Guidance: Expected in the range of $1.4bn – $1.6bn.
  • Reported Insurance Margin: 13.5% – 15.5%, expected toward the upper end.
  • Premium Growth: Likely to be at the lower end of previous expectations.
  • Business Interruption Provision Release: $140m post-tax release, not expected to be recurring.

Market Positioning

As of February 12, 2025, Insurance Australia Group Limited (ASX: IAG) is trading at $8.92 per share. The current price is about 3.1% below its 52-week high of $9.21, reached on January 31, 2025.

Market Expectations

  • The results delivered strong profit growth but fell short on revenue expansion and dividends, leading to a significant share price decline.
  • Investors appear concerned that growth in premium income is slowing, which may impact future revenue and earnings potential.

Final Thought: Quick Take: H1FY25 ASX:IAG

While IAG posted strong profitability and margin expansion, the market’s focus on slowing premium growth and cautious guidance has overshadowed the result. Investors will likely watch how management balances growth, cost control, and capital returns in the coming quarters.

Insurance Australia Group ASX:IAG - 12 month daily chart with volume and three exponential moving averages to help quickly determine the trend.


“This information is provided purely for educational purposes. It takes no account of an individual’s personal financial circumstances and hence can in no way constitute financial advice. The above data may be subject to errors or inconsistencies for which the author takes no liability. It is imperative that all investors do their own research or if they need advice, seek it from a qualified financial adviser.”

Quick Take: H1FY25 ASX:IAG

Quick Take: H1FY25 ASX:DOW

Downer Group – 2025 Interim Results Summary

https://www.downergroup.com

Overall Tone

The report conveys a positive and confident tone, emphasizing that Downer’s turnaround strategy is on track. The company highlights improvements in earnings, cost efficiencies, and margin growth while acknowledging softer conditions in certain markets.

Key Financial Metrics (Compared to 1H24)

Metric 1H25 1H24 Change
Revenue $5.5bn $5.79bn ▼5.2%
EBITA $204.4m $149.1m ▲37.1%
EBITA Margin 3.7% 2.6% ▲1.1pp
NPATA $127.3m $74.9m ▲70%
NPAT $75.5m $72.1m ▲4.7%
Operating Cash Flow $220.1m $168.2m ▲30.9%
Free Cash Flow $112.5m $19.9m ▲>100%
Net Debt to EBITDA 1.3x 1.4x Improved

Revenue & Earnings Analysis

  • Revenue decreased 5.2% due to divestments and reduced government transport spending.
  • EBITA grew 37.1%, reflecting strong cost reduction efforts and operational improvements.
  • EBITA margin increased by 1.1 percentage points to 3.7%, driven by enhanced contract management and disciplined risk-taking.

Operating Cash Flow

  • Cash conversion improved to 94%, strengthening the balance sheet.
  • Free cash flow surged to $112.5m, a significant improvement from $19.9m in 1H24.

Outlook & Guidance

  • The company remains confident in its turnaround strategy, targeting an underlying NPATA of $265m – $280m for FY25.
  • EBITA margins are expected to exceed 4.5% in FY26, with a minimum threshold of 4.2% in FY25.
  • Strong tender pipeline in 2H25 across Defence, Telecommunications, Power, and Road Maintenance.
  • Market conditions remain varied, with lower Australian transport spending and a softer New Zealand economy.

Observations on Market Expectations

The result appears broadly in line with expectations, with stronger-than-expected cost savings and EBITA growth balancing out weaker revenue. The continued turnaround progress and margin expansion could be seen as a positive surprise.

Downer Group ASX:DOW - 12 month daily chart with volume and three exponential moving averages to help quickly determine the trend.


“Disclaimer: This information is provided purely for educational purposes. It takes no account of an individual’s personal financial circumstances and hence can in no way constitute financial advice. The above data may be subject to errors or inconsistencies for which the author takes no liability. It is imperative that all investors do their own research or if they need advice, seek it from a qualified financial adviser.”

Quick Take: H1FY25 ASX:DOW

Quick Take: H1FY25 ASX:TWE

Treasury Wine Estates – 2025 Interim Results Summary

https://www.tweglobal.com/

Overall Tone

Treasury Wine Estates (TWE) results indicate a strong performance, with notable increases in revenue, profitability, and margins. The company continues to benefit from premiumization, strong growth in its Penfolds brand, and the integration of DAOU Vineyards. However, increased costs and restructuring efforts are worth monitoring.


Key Financial Metrics (Half-Year Ended 31 December 2024)

Metric 1H FY25 1H FY24 % Change
Revenue $1,570.4M $1,313.4M +19.6%
EBITDA (EBITS) $391.4M $289.8M +35.1%
Net Profit After Tax (NPAT) $220.9M $166.7M +32.5%
Operating Cash Flow $259.6M $149.0M +74.2%
Earnings Per Share (EPS) 27.2 cps 22.5 cps +21%
Interim Dividend 20.0 cps 17.0 cps +17.6%

Revenue & Profitability Trends

  • Revenue growth of 19.6% was driven by strong demand for luxury wine, particularly in the Penfolds portfolio, and the contribution of DAOU Vineyards.
  • EBITS margin expanded to 25.3% (up from 22.5%), reflecting improved pricing and a premium product mix.
  • Operating cash flow increased by 74.2%, showing strong cash generation and efficient capital management.

Earnings Before Tax (EBT)

  • EBT increased 42% to $322M, supported by higher revenue and cost efficiencies.
  • Finance costs rose slightly due to higher debt levels, but the overall impact was manageable.

Outlook Commentary

  • TWE remains focused on premiumization and expects further growth from Penfolds and DAOU Vineyards.
  • Expansion in China and other Asian markets is progressing well, with strong sales momentum.
  • Cost pressures are being managed through price increases and operational efficiencies.

Guidance Statements

  • The company did not provide formal earnings guidance but expects continued margin expansion and strong organic revenue growth.
  • Further integration of DAOU Vineyards is expected to contribute positively to earnings.
  • The dividend reinvestment plan (DRP) remains active, reflecting confidence in cash flow sustainability.

Market Expectations & Observations

  • Results exceeded market expectations, particularly in revenue and earnings growth.
  • The interim dividend increase suggests confidence in future performance.
  • Investors will watch cost management and further integration of acquisitions.

Treasury Wine Estates ASX:TWE - 12 month daily chart with volume and three exponential moving averages to help quickly determine the trend.


Disclaimer

Disclaimer: This information is provided purely for educational purposes. It takes no account of an individual’s personal financial circumstances and hence can in no way constitute financial advice. The above data may be subject to errors or inconsistencies for which the author takes no liability. It is imperative that all investors do their own research or if they need advice, seek it from a qualified financial adviser.

Quick Take: H1FY25 ASX:TWE

Quick Take: H1FY25 ASX:PME

Pro Medicus Limited – 2025 Interim Results Summary

https://www.promed.com.au/

Overall Tone

Pro Medicus Limited (PME) has delivered exceptional financial results for the half-year ended 31 December 2024, reflecting strong revenue growth, margin expansion, and increasing profitability. The company’s North American expansion and contract wins have significantly contributed to this above-market performance, alongside disciplined cost management and robust cash flow generation.


Key Financial Metrics

Metric H1 FY25 (31 Dec 2024) H1 FY24 (31 Dec 2023) Change (%)
Revenue ($’000) 97,190 74,110 +31.1%
EBITDA ($’000) N/A N/A
EBT ($’000) 73,272 50,162 +46.1%
NPAT ($’000) 51,745 36,250 +42.7%
Operating Cash Flow ($’000) 48,710 28,988 +68.1%
Net Cash & Financial Assets ($’000) 182,330 154,900 +17.7%
Interim Dividend (cents per share) 25.0 18.0 +38.9%

Performance Analysis

Revenue Growth

  • Revenue surged 31.1% to $97.2 million, driven by strong growth in North America (+34.6%), contract renewals, and increasing adoption of PME’s software solutions.
  • On a constant currency basis, revenue would have been $97.84 million (+32.0%).
  • Growth in Europe (+0.8%) and Australia (+10.8%) was modest but steady.

EBT & NPAT

  • Earnings before tax (EBT) rose 46.1% to $73.27 million, reflecting strong operating leverage.
  • Net profit after tax (NPAT) increased by 42.7% to $51.75 million, demonstrating margin expansion and cost efficiencies.

Cash Flow & Balance Sheet Strength

  • Operating cash flow surged 68.1% to $48.71 million, highlighting PME’s strong cash generation ability.
  • Cash reserves increased by $24.48 million, despite higher dividend payouts.
  • PME remains debt-free, positioning it well for future expansion and strategic investments.

Dividend Increase

  • Interim dividend raised to 25.0 cents per share (vs. 18.0 cents in H1 FY24), representing a 38.9% increase.
  • Reflects management confidence in PME’s earnings growth and commitment to shareholder returns.

Outlook Commentary

  • PME is well-positioned for continued growth, particularly in North America, where it secured $365 million in new contracts across Lurie Children’s Hospital, Trinity Health, and Duly Health & Care.
  • Contract renewals with NYU Langone, Duke Health ($39 million, 5-year deals), and Mercy Health ($98 million, 8-year deal) provide a long-term revenue base.
  • Investment in AI-driven imaging solutions and R&D continues to support PME’s competitive edge.
  • The company remains focused on academic hospitals, integrated delivery networks (IDNs), and corporate imaging centers, expanding its global footprint.

Guidance Statements

  • No formal guidance was provided, but the growth trajectory remains strong.
  • The company’s cash reserves and contract backlog suggest continued revenue expansion.

Market Expectation vs. Actual Performance

  • Given the strong revenue growth, margin expansion, and contract pipeline, PME’s results likely exceeded market expectations.
  • North American contract wins and strong cash flow generation are major positives.
  • The 38.9% increase in dividend payout signals management confidence.
  • The market may react positively, given PME’s high-growth profile, expanding margins, and cash generation strength.

Per Share Analysis

Metric H1 FY25 H1 FY24 Change (%)
Earnings per Share (EPS) 49.53 cents 34.71 cents +42.7%
Diluted EPS 49.44 cents 34.61 cents +42.9%
Interim Dividend per Share 25.0 cents 18.0 cents +38.9%

Conclusion

Pro Medicus Limited delivered outstanding H1 FY25 results, with exceptional revenue growth (+31.1%), profit expansion (+42.7%), and cash flow strength (+68.1%). The strong contract wins, high-margin business model, and disciplined capital allocation position PME for continued outperformance. The increase in dividend payout (+38.9%) further reinforces management’s confidence in sustained growth.

PME’s results likely exceeded market expectations, and the stock may react positively given its strong fundamentals, debt-free balance sheet, and strategic expansion plans.

Pro Medicus ASX:PME - 12 month daily chart with volume and three exponential moving averages to help quickly determine the trend.


Disclaimer: This information is provided purely for educational purposes. It takes no account of an individual’s personal financial circumstances and hence can in no way constitute financial advice. The above data may be subject to errors or inconsistencies for which the author takes no liability. It is imperative that all investors do their own research or if they need advice, seek it from a qualified financial adviser.

Quick Take: H1FY25 ASX:PME

Quick Take: H1FY25 ASX:TPW

Temple & Webster Group Ltd – 2025 Interim Results Summary

https://www.templeandwebster.com.au/

Overall Tone

The financial results for Temple & Webster Group Ltd (TPW) for the half-year ended 31 December 2024 indicate a strong and positive performance. The company has achieved robust revenue growth, significantly improved profitability, and strong cash flow generation. Operational efficiency gains, strategic investments in AI, and an increase in exclusive product offerings have contributed to the better-than-expected financial performance.


Key Financial Metrics

Metric H1 FY25 (31 Dec 2024) H1 FY24 (31 Dec 2023) Change (%)
Revenue ($’000) 313,710 253,827 +24%
EBITDA ($’000) 13,168 7,473 +76%
EBITDA Margin (%) 4.2% 2.9% +130bps
EBT ($’000) 12,466 6,428 +94%
NPAT ($’000) 8,980 4,125 +118%
Operating Cash Flow ($’000) 35,064 21,906 +60%
Net Tangible Assets per Share (cents) 81.3 64.25 +27%

Performance Analysis

Revenue

  • TPW achieved $313.7 million in revenue, representing a 24% increase YoY.
  • Growth was driven by record active customers (~1.2 million) and an increase in revenue per active customer (+2%).

EBITDA

  • EBITDA surged 76% to $13.2 million, reflecting margin expansion to 4.2% (vs. 2.9% YoY).
  • This was aided by cost discipline, AI-driven efficiencies, and improved gross margins.

Operating Cash Flows

  • Operating cash flow improved 60% to $35.1 million, showing strong cash conversion.
  • Free cash flow was $32.5 million, highlighting TPW’s capital-light business model.

Earnings Before Tax (EBT)

  • Pre-tax earnings almost doubled (+94%) to $12.5 million, demonstrating strong operational leverage.

Net Profit After Tax (NPAT)

  • NPAT more than doubled to $9.0 million (+118%), significantly outpacing revenue growth.

Outlook Commentary

  • TPW remains on track to achieve its mid-term goal of $1 billion+ in annual revenue within 3-5 years.
  • Expansion in exclusive products (45% of revenue) and further AI-driven efficiencies expected to drive margin expansion.
  • Market share increased by 23% to 2.9%, reinforcing TPW’s growing dominance in the online furniture and homewares segment.

Guidance Statements

  • No formal guidance was provided for FY25.
  • The company maintains a strong balance sheet with $139.3 million in cash, positioning it well for further growth initiatives.

Market Expectation vs. Actual Performance

  • Given the strong revenue growth, significant profit expansion, and high cash flow conversion, TPW’s results likely exceeded market expectations.
  • The company’s ability to scale efficiently while improving profitability is a positive surprise.
  • If the market expected a more moderate earnings growth, these results may lead to a positive share price reaction.

Per Share Analysis

Metric H1 FY25 H1 FY24 Change (%)
Earnings per Share (EPS) 7.57 cents 3.45 cents +119%
Diluted EPS 7.20 cents 3.30 cents +118%
Net Tangible Assets per Share 81.3 cents 64.25 cents +27%

Conclusion

Temple & Webster delivered a standout H1 FY25 performance, with strong revenue growth, significant margin expansion, and robust cash generation. AI-driven efficiencies and increasing penetration of exclusive products provide a clear path to further earnings growth. The company’s market share gains and disciplined cost structure position it well for continued outperformance.

Temple & Webster ASX:TPW - 12 month daily chart with volume and three exponential moving averages to help quickly determine the trend.


Disclaimer: This information is provided purely for educational purposes. It takes no account of an individual’s personal financial circumstances and hence can in no way constitute financial advice. The above data may be subject to errors or inconsistencies for which the author takes no liability. It is imperative that all investors do their own research or if they need advice, seek it from a qualified financial adviser.

Quick Take: H1FY25 ASX:TPW

Short Selling: Advanced Concepts

The following is a discussion with ChatGPT delving deeper into some advanced concepts in short selling.


Q1. I want to better understand the mechanics of short selling. Is it true that it involves an entity borrowing stock from another entity, paying them a fee for the privilege, selling them on the market and then buying them back and returning them to the lender at some future time?

Yes, that’s a solid high-level summary of how short selling works. Let’s break it down step by step with some additional details:

1. Borrowing the Shares

  • A short seller (often a hedge fund or a trader) wants to bet that a stock’s price will decline.
  • They borrow shares from a broker or institutional lender (such as a pension fund or mutual fund), who owns the shares.
  • The borrower typically pays a fee (stock loan fee) to the lender for the privilege of borrowing the shares. This fee depends on how difficult the stock is to borrow (highly shorted stocks tend to have higher borrowing costs).

2. Selling the Borrowed Shares

  • Once the shares are borrowed, the short seller immediately sells them on the open market, hoping to buy them back later at a lower price.
  • The proceeds from this sale go into the short seller’s brokerage account, but they are often required to maintain margin collateral (a portion of the sale proceeds must be set aside as security).

3. Buying Back the Shares (Covering the Short)

  • At some point in the future, the short seller buys back the shares on the open market.
  • If the stock price has declined, they buy it at a lower price than they sold it for, locking in a profit.
  • If the stock price has increased, they must buy it back at a higher price, resulting in a loss.

4. Returning the Shares to the Lender

  • The short seller returns the borrowed shares to the original lender.
  • The lender gets their shares back, along with any fees earned from lending them out.

Key Considerations:

  • Margin Requirements: Because shorting involves borrowing, traders need sufficient margin (collateral) in their account.
  • Unlimited Loss Potential: Since stock prices can, in theory, rise indefinitely, a short seller’s losses are theoretically unlimited.
  • Short Squeeze Risk: If many traders are short a stock and it starts rising sharply, they may be forced to buy back shares to cover their positions, causing the price to surge further (this is called a short squeeze).
  • Dividends and Corporate Actions: If a stock pays a dividend while being shorted, the short seller must pay the dividend to the lender. Stock splits, mergers, and other corporate actions can also impact short positions.

Q2. Ok great. So my next question is this. Once the shares have been leant, does the lender no longer own the shares and hence no longer has any voting rights over those shares?

Yes, that’s correct. Once an entity lends out its shares for short selling, it temporarily loses ownership rights, including voting rights. Here’s how it works:

1. Loss of Voting Rights

  • When an investor (e.g., a pension fund or mutual fund) lends shares to a short seller, they no longer own the shares during the loan period.
  • This means they lose their right to vote on corporate matters (e.g., board elections, mergers, shareholder proposals) because they are not the registered owner of the shares at the time of voting.

2. Who Holds the Voting Rights?

  • The short seller does not have voting rights either because they don’t intend to keep the shares—they are selling them.
  • The new buyer of the shares (the person who buys them from the short seller) now owns the shares and gains the voting rights.

3. Can the Lender Recall Shares for Voting?

  • Some lenders (especially large institutional investors) have agreements that allow them to recall their lent shares before key votes (such as takeovers or shareholder activism events).
  • If they recall the shares, the short seller is forced to buy them back and return them before the vote.

4. Potential Market Impact

  • In cases of contested votes, large-scale stock lending can reduce the influence of passive funds or institutional investors, shifting voting power to traders who may have different incentives.
  • Activist investors sometimes try to borrow shares before a vote to influence corporate decisions, though regulations exist to prevent abuses.

Q3. So if the shares were borrowed from say a pension fund, would those shares need to sit outside of a portfolio that may be tracking an index? I mean, if they have been sold, they’re no longer in alignment with the index, right?

Great question! Yes, when a pension fund (or any index-tracking fund) lends out shares, those shares are no longer in their direct possession, which could seemingly create a misalignment with the index they are tracking. However, funds have mechanisms to manage this and maintain index alignment.

1. Collateral Ensures Economic Exposure

  • When an index fund or pension fund lends out shares, they typically receive collateral in return (usually in the form of cash or other securities).
  • The fund still retains economic exposure to the stock even though it no longer physically holds the shares.
  • If the stock price changes, the value of the fund’s assets (including the collateral) still reflects those changes, ensuring that the fund tracks the index effectively.

2. Securities Lending as a Common Practice in Index Funds

  • Many index-tracking funds (like ETFs and pension funds) engage in securities lending as a way to generate extra income.
  • The fees they earn from lending shares can offset tracking errors and even improve fund performance.
  • To prevent any major tracking errors, they often lend only a portion of their holdings rather than all their shares.

3. Portfolio Management Strategies

  • Some funds will use derivatives (such as futures or swaps) to maintain exposure to the index even if they have lent out shares.
  • Others may hold back a percentage of shares (i.e., not lend all shares they own) to ensure they always have enough in their portfolio.

4. Does Lending Affect Index Tracking?

  • In theory, lending shares means the fund no longer directly holds them, but in practice, the collateral + income from lending offsets the impact.
  • The fund manager ensures that the portfolio remains in line with the index through careful lending policies.

5. What Happens if the Shares Are Recalled?

  • If a fund needs to recall shares (e.g., for voting or rebalancing), it requests them back from the borrower, who must then return them.
  • If the borrower can’t return them in time, the fund buys back shares on the market, which could introduce a small tracking error.

Bottom Line

A pension fund or index fund can lend out shares while still tracking the index, thanks to collateral and careful risk management. However, lending out too many shares could introduce tracking errors, which is why funds implement limits on how much they lend at any given time.


Q4. Does it ever result in say an index fund buying more than the index weighting to then lend shares and to the degree that it brings them back to weight? I guess what I’m asking is, do some of the big ETF managers increase their holdings in underperforming stocks to satisfy demand from hedge funds to access shares to sell short?

Yes, that’s a sharp observation! While index funds generally aim to track their benchmark exactly, there are cases where large ETF and index fund managers might adjust their holdings slightly to take advantage of securities lending opportunities. Here’s how and why it happens:

1. ETF Managers Want to Maximize Lending Income

  • Major ETF providers like BlackRock (iShares), Vanguard, and State Street (SPDRs) earn extra revenue from lending stocks to short sellers.
  • If there’s high demand for shorting a particular stock (e.g., struggling companies, meme stocks, or highly shorted sectors), the stock’s lending fees can be quite lucrative.
  • To capitalize on this, some ETF managers might slightly overweight these stocks, increasing their lending revenue while still maintaining acceptable tracking error.

2. How It Works in Practice

  • Most index funds try to match the exact weightings of an index like the S&P 500, NASDAQ-100, or ASX 200.
  • However, within their tracking strategies, they have some flexibility:
    • Full Replication: Buying all stocks in exact proportion (common in large, liquid indices).
    • Sampling: Holding slightly different proportions or a subset of stocks (used in less liquid markets).
  • Some funds take advantage of this flexibility to increase their position slightly in highly lendable stocks.

3. Why This Matters for Underperforming Stocks

  • When a stock is heavily shorted, hedge funds and traders need to borrow shares to execute their short trades.
  • The fees on lending highly shorted stocks can be substantial (e.g., GameStop during the short squeeze, Tesla in the early days).
  • If an ETF provider knows there is persistent demand for shorting a stock, they may hold a bit more than the index weight, earning lending fees that offset expenses and improve fund performance.
  • This is especially tempting for passive ETFs with low management fees, where every extra basis point of return from lending is valuable.

4. Does This Affect Market Behaviour?

  • If large ETFs overweight underperforming stocks just to lend them out, it could create a supply/demand imbalance, where more shares are available for shorting than natural buyers.
  • This could potentially increase short interest and contribute to downward price pressure on already weak stocks.
  • On the flip side, if a short squeeze occurs, ETF managers might recall their lent shares, forcing shorts to cover and driving prices higher.

5. Regulatory & Risk Considerations

  • Index funds still need to closely track their benchmark, so they can’t deviate too much.
  • There are regulatory limits on how much an ETF can lend out (often around 30% of holdings for U.S. ETFs).
  • If they overweight a stock too aggressively and it drops further, they risk higher tracking error or liquidity issues.
  • Some funds cap their securities lending exposure to mitigate risk.

Conclusion

Yes, some large ETF managers strategically adjust their holdings to take advantage of securities lending opportunities, particularly in underperforming stocks with high short-selling demand. However, they must balance this with tracking accuracy and regulatory constraints.


Short Selling: Advanced Concepts

5 Stocks with Rising Short Interest

Introduction

Based on the characteristics identified in my article “Most shorted ASX Stocks 5/2/25” the following stocks look like they could be in the early stages of a shift in sentiment in the eyes of the short sellers. That could potentially signal price further price declines are to come.

Stock #1: Polynovo ASX:PNV

2025 estimated PER: 196.5 | Debt: Minimal | Cash: $46M | Operating Cash Flows: Just recently positive

Clearly the biggest concern for holders of this stock is the valuation. There is plenty of room for the stock to move lower and for the stock to still look expensive. As we’ve seen in the previous article, short-sellers like a big runway for the stock to potentially fall and they certainly have that with PNV.

 

5 Stocks with Rising Short Interest - ASX:PNV 12 month price chart with moving averages and volume along with a short position graph over the same time period

Stock #2 Zip Co ASX:ZIP

2025 estimated PER: 77.7 | Debt: $2.4B | Cash: $125M | Operating Cash Flows: Just recently positive

Again there is plenty of valuation downside for ZIP. Unlike PNV, they also have an enormous debt balance. Growth in Australia was negative when they last reported while they continue to do well in the US. On a per share basis though, revenue growth has been slowing. As we saw in the previous article. the short sellers love highly valued stocks that are showing a slowing in growth. ZIP fits that criteria. Another concern is the recent 100% sell-down by founder Larry Diamond.

5 Stocks with Rising Short Interest - ASX:ZIP 12 month price chart with volume and moving averages and short position chart

Stock #3 Lovisa ASX:LOV

2025 estimated PER: 29.3 | Debt: $359M | Cash: $35M | Operating Cash Flows: Very comfortable

This stock looks the least vulnerable on a fundamental basis. Valuation is high but acceptible considering the rate at this company has been growing since 2020 especially. Nevertheless, the short sellers are seeing something that has got them excited. I have seen some headlines suggesting there are some new competitors entering Lovisa’s market. If they were to take market share and reduce the growth rates of Lovisa, then a 30 PER will be much harder to justify.

5 Stocks with Rising Short Interest: Lovisa 12 month price chart with volume and moving averages and a short positions chat

Stock #4 Neuren Pharmaceuticals ASX:NEU

2025 estimated PER: 25.8 | Debt: None | Cash: $213M | Operating Cash Flows: Comfortable

The stock already has a lot of downward price momentum having fallen 42% in the past 12 months. While the short sellers have ridden the stock lower, increasing their positions along the way, they are still below 5%.While NEU has a great deal of potential, it also has its risks. The new administration in America and in particularly the new Health Minister add to the uncertainties. Drugs in development are great if they come-off but there’s always a chance they don’t. Sales of the their primary drug have been steadily increasing but there are other drugs being developed in the same field. The short sellers are showing no signs of going away yet.

ASX:NEU 12 month price chart with volume and moving averages plus a short position chart overt the same period

Stock #5 Whitehaven Coal ASX:WHC

2025 estimated PER: 7.4 | Debt: $1.8B | Cash: $405M | Operating Cash Flows: Declining

Easy to look at WHC and think “surely they can’t go any lower”. That is until you realise they were actually loss-making in 2021 and pretty much had a break-even year in 2020. From 2012 to 2016 they flipped between small profits and small losses. $1.8B in debt is nothing to take lightly either. Add to that the fact that the coal price is in a well defined downtrend and it’s not hard to see why the short-sellers are increasing their bets against this company.

ASX:WHC 12 month price chart with volume and moving averages plus a short position chart over the same period

Coal Price

1 year coal price chart

Conclusion: 5 Stocks with Rising Short Interest

While each of these stocks presents a unique set of risks and challenges, the common thread among them is their appeal to short sellers due to high valuations, slowing growth, or broader industry uncertainties. Polynovo and Zip Co stand out for their significant valuation risks, with ZIP further burdened by substantial debt and declining growth metrics. Lovisa appears more fundamentally resilient, but emerging competition may be fueling short interest. Neuren Pharmaceuticals carries the inherent risks of biotech investing, with regulatory uncertainties adding to short-seller concerns. Meanwhile, Whitehaven Coal’s declining cash flows and a weak commodity price environment make it a compelling target for bearish traders.

While short interest alone is not a definitive predictor of future price movements, it often signals underlying concerns that should not be ignored. Investors should carefully assess these factors and consider whether the risks highlighted by short sellers align with their own investment thesis.

 


Disclaimer: This information is provided purely for educational purposes. It takes no account of an individual’s personal financial circumstances and hence can in no way constitute financial advice. The above data may be subject to errors or inconsistencies for which the author takes no liability. It is imperative that all investors do their own research or if they need advice, seek it from a qualified financial adviser.

5 Stocks with Rising Short Interest

5 Stocks Offering Growth and Value

Stock #1: Select Harvests (ASX: SHV) – A Comeback Story

https://selectharvests.com.au/

5 Stocks Offering Growth and Value - SHV 12 month price chart with exponential moving averages and volume

Select Harvests ASX:SHV Short Positions over the last 12 months

 

Investment Thesis

1. Leading Position in a Growing Market
Select Harvests is Australia’s largest almond producer and the third-largest globally. The company operates extensive orchards across Victoria, New South Wales, and South Australia, positioning it well to capitalize on rising global demand for almonds, driven by consumer preferences for healthy and plant-based foods.

2. Operational Efficiency and Yield Improvements
The company has implemented strategies to enhance production volumes and cost efficiencies. Recent horticultural investments, such as frost protection measures, have led to significant yield improvements and cost reductions. A 32% production increase was achieved through expanding almond-bearing acreage and a 23% yield increase.

3. Favorable Industry Dynamics
Global almond consumption has grown by 6-8% annually, fueled by health-conscious consumers and the shift toward plant-based diets. Additionally, California’s ongoing water scarcity issues (responsible for 80% of global almond supply) may constrain future production, potentially benefiting Select Harvests.

4. Positive Outlook and Strategic Initiatives
Despite recent weather-related challenges, Select Harvests maintains a positive crop outlook. The company focuses on:
Enhancing orchard yield and quality
Securing water resources
Reducing operational costs
Exploring new growth opportunities

5. Financial Position and Capital Management
The company maintains a strong balance sheet and has undertaken capital-raising initiatives to support expansion. A recent AU$80 million capital raise will help boost processing capacity and operational efficiencies.

📌 Summary: Select Harvests’ leading market position, operational efficiencies, favorable industry trends, and strong financial management make it a compelling investment opportunity.

LA Wildfires – Industry Impact

The recent Los Angeles wildfires have not directly impacted almond production, as the primary almond-growing regions in California’s Central Valley lie north of LA. However, wildfires contribute to broader environmental challenges affecting agriculture statewide.

Key concerns include:
🌱 Severe drought conditions – 100% of Los Angeles County is drought-affected, with December 2024 ranking as the 10th driest month in 130 years.
🌱 Almond trees’ high water requirements – Prolonged drought may reduce yields and quality.
🌱 Smoke exposure – Research shows wildfire smoke can negatively impact nut production.

📌 Conclusion: While the LA fires themselves are not an immediate threat, ongoing drought conditions and climate concerns pose challenges to California’s almond industry.

ASX:SHV fundamentals

Select Harvest - Site Tour March 18, 2025 - China Daily Nuts

Stock #2: GenusPlus Group (ASX: GNP) – In the Right Place at the Right Time

https://www.genus.com.au/

5 Stocks Offering Growth and Value - GNP 12 month price chart with exponential moving averages and volume

Investment Thesis

1. Strategic Positioning in Growth Sectors
GenusPlus operates in power and communications infrastructure, uniquely positioned to capitalize on Australia’s investment in:
Renewable energy projects
Battery Energy Storage Systems (BESS)
Power transmission modernization

Its expertise in engineering, procurement, and construction (EPC) gives it a competitive edge in Australia’s energy transition.

2. Strong Financial Performance
📈 FY24 net profit: $19.3M (up from $13.4M in FY23)
📈 EPS rose to 10.8 cents, reflecting efficient operational execution and expansion

3. Major Contract Wins
GenusPlus has secured high-value contracts, including:
600MW/1,600MWh BESS project for Melbourne Renewable Energy Hub (~$200M)
Defense infrastructure contract ($16M) for Shoalwater Bay

4. National Expansion and Diversification
Originally focused in Western Australia, GenusPlus has expanded nationally via acquisitions and organic growth. New Queensland branches and diversification into defense infrastructure enhance its market reach.

5. Experienced Leadership & Insider Confidence
🚀 Managing Director David Riches has made significant insider share purchases, reinforcing strong confidence in the company’s outlook.

📌 Summary: GenusPlus’ positioning in high-growth sectors, solid financials, major contracts, national expansion, and strong leadership support a compelling investment thesis.

GNP fundamentals

Genus Plus Presentation Slide March 13, 2025 - HY2025 Financial Highlights

Genus Plus Presentation Slide March 13, 2025 - Segments & Group Snapshot

Stock #3: Kina Securities (ASX: KSL) – Growth, Income & Value

https://investors.kinabank.com.pg/Investors/

5 Stocks Offering Growth and Value - KSL 12 month price chart with exponential moving averages and volume

Investment Thesis

1. Diversified Financial Services Portfolio
Kina Securities operates in banking, finance, and wealth management, serving PNG’s growing financial sector.

2. Strong Financial Performance
💰 P/E ratio: 6.87
📈 Return on Equity (ROE): 16.8%

3. High Dividend Yield
📊 7.7% dividend yield, making Kina a strong income play.

4. Market Position in PNG
🏦 Second-largest banking institution in PNG with strong local brand recognition.

5. Digital Transformation Strategy
📲 Investment in digital banking, mobile services, and fintech partnerships strengthens competitive positioning.

📌 Summary: Kina offers a blend of growth, income, and value, supported by strong financials, high dividends, and strategic digital investments.

ASX:KSL fundamentals

Kina Securities TIP Group Presentation March 13, 2025 - PNG Economy slide

Kina Securities TIP Group Presentation March 13, 2025 - Market share gains

Stock #4: Evolution Mining (ASX: EVN) – Undervalued Compared to Peers

https://evolutionmining.com.au/

5 Stocks Offering Growth and Value - ASX:EVN 12 month price chart with exponential moving averages and volume

Investment Thesis

1. Strong Asset Portfolio & Operational Excellence
🌍 Top-tier mining assets: Cowal, Ernest Henry, Northparkes, Mungari, and Red Lake
📈 FY24 net profit: $422M
🏅 Gold production: 716,700 oz | Copper: 67,862 tonnes

2. Growth & Diversification
🛠 80% stake in Northparkes boosts copper output by 50%
🔀 Copper now 30% of total revenue (reduces reliance on gold)

3. Financial Strength & Shareholder Returns
💰 $716M liquidity | Gearing down from 33% to 25%
💵 Final dividend doubled to 5 cents per share

📌 Summary: Evolution’s diversified asset portfolio, strong financials, and strategic copper expansion make it undervalued relative to peers.

ASX:EVN fundamentals

BMO Global Metals & Mining Conference Presentation February 24, 2025 - Business snapshot slide

BMO Global Metals & Mining Conference Presentation February 24, 2025 - Peer margin comparison

Stock #5: Cuscal Limited (ASX: CCL) – A New Listing with a Low Valuation

https://www.cuscal.com/

CCL price chart with exponential moving averages and volume

Investment Thesis

1. Payments Infrastructure Leader
🏦 Key player in Australia’s payments ecosystem | Connects banks, fintechs, and corporates.

2. Competitive Moat
🔒 Only non-major bank offering end-to-end payment processing.

3. Strong IPO & Financial Performance
📊 FY24 revenue: $284.5M (+18%) | Net profit: $32.9M
📈 IPO raised $337M for growth and system enhancements.

4. Expansion & Growth Potential
🚀 Investing in regulated data services & market share growth.

📌 Summary: Cuscal’s dominance in payments, strong IPO, and growth strategy make it a potentially attractive long-term investment.

 

5 Stocks Offering Growth and Value -ASX:CCL fundamentals

Cuscal Slide: Small Caps presentation 26/3/25

Cuscal FY25 Highlights slide - Small Caps presentation 26/3/25

Final Thought: 5 Stocks Offering Growth and Value

In a market where growth, resilience, and strategic positioning define success, these five ASX-listed companies showcase compelling investment cases across diverse sectors. From Select Harvests’ potential almond industry tailwinds to GenusPlus’ role in Australia’s energy transition, each presents a unique opportunity backed by strong fundamentals. Kina Securities offers a rare mix of value and income, Evolution Mining is leveraging its copper expansion for long-term upside, and Cuscal’s payments infrastructure dominance sets it apart as a fresh listing with strong potential. While risks remain, particularly with external factors like climate change and economic conditions, these companies may just have the strategies in place to navigate challenges and capitalise on emerging opportunities.

 


Disclaimer: This information is provided purely for educational purposes. It takes no account of an individual’s personal financial circumstances and hence can in no way constitute financial advice. The above data may be subject to errors or inconsistencies for which the author takes no liability. It is imperative that all investors do their own research or if they need advice, seek it from a qualified financial adviser.

5 Stocks Offering Growth and Value

Short Selling Case Study ASX:ACL

Introduction

The aim of this Short Selling Case Study ASX:ACL is to examine what happens when the market shifts against short-sellers in a heavily shorted stock. Many investors follow stocks with high short interest because, if conditions improve, the unwinding of short positions can fuel a sharp rally. But what causes these reversals, and how can investors recognize the signs early? Let’s take a look at Australian Clinical Labs (ASX: ACL) as a case study.

Short Squeeze?

I wouldn’t go so far to label this as a short-squeeze, but more of an aggressive exit. For context, a short-squeeze occurs when short sellers become trapped due to a dramatic increase in demand for a heavily shorted stock. [refer to my article on short-selling for two examples of a short-squeeze].

In the case of ASX:ACL, business conditions have improved but not substantially and not in a way that is really surprising. The short sellers would have anticipated that this would happen one day and appear to have been ready to react. They were not trapped nor overwhelmed by buyers. Nevertheless, this “orderly” rally still saw the share price jump 50% in the space of around 2 months.

Australian Clinical Labs (ASX:ACL)

ACL was a big winner during COVID-19, benefiting from high demand for pathology testing. However, as pandemic-related testing volumes declined, so did earnings and investor confidence.

Short Selling Case Study ASX:ACL - EPS chart with forecasts

The decline in earnings in 2023 and 2024 was flagged to cease in the companies full-year results in August 2024. An increased dividend and a share buy-back were also positive for shareholders and negative for anyone that had sold the stock short.

ACL FY24 Market update

It is clear that the share price reversed when that became apparent. It has also coincided with the short sellers aggressively cutting their short positions from over 10% to less than 2%. In 6 months, the share price is up over 50% as a result.

Short Selling Case Study ASX:ACL - 12 months share price vs 12 month short positions charts

Conclusion

When a heavily shorted stock begins to recover, the resulting price movement can still be substantial, even without a full-blown short squeeze. In the case of Australian Clinical Labs (ASX: ACL), short-sellers were not caught off guard, but they still acted quickly to unwind their positions. This more orderly exit helped drive a 50% share price increase in just a few months.

However, this example also reinforces the discipline of short-sellers. They are rarely caught by surprise and often time their exits well, as seen with ACL. As discussed in my top 20 most shorted ASX stocks analysis, they tend to be right far more often than they are wrong.

📌 Key Takeaway:
Short interest can be a valuable signal, but not every stock with high short interest will experience a squeeze. Instead, investors should watch for signs of improving fundamentals, corporate actions, and short covering to gauge potential opportunities. The biggest moves often come when short-sellers exit in unison, whether gradually or in a rush.

 


Disclaimer: This information is provided purely for educational purposes. It takes no account of an individual’s personal financial circumstances and hence can in no way constitute financial advice. The above data may be subject to errors or inconsistencies for which the author takes no liability. It is imperative that all investors do their own research or if they need advice, seek it from a qualified financial adviser.

Short Selling Case Study ASX:ACL

Most Shorted ASX Stocks 5/2/25

The top 20 ASX companies with the highest short-sold positions:

Most Shorted ASX Stocks 5/2/25

Source: https://stocksunderthehood.com/asx-most-shorted-stocks/

Let’s examine why a significant percentage of these companies’ shares are being shorted, indicating that traders are betting on their share prices falling.

Uranium (BOE, PDN & DYL)

Boss Energy (BOE): Medium term, share price falling, Shorts rising

Paladin (PDN): Medium term, share price falling, Shorts rising

Deep Yellow (DYL): Medium term, share price flat, Shorts rising

Nuclear demand is supposed to be increasing right? Uranium is a great investment right?

Most Shorted ASX Stocks 5/2/25 - Uranium price and some key ASX Uranium stocks chart

The blue line in the chart represents the spot uranium price, which has fallen 33% from its peak. This may surprise some, as much of the commentary around uranium has been bullish. However, the short positions in these three uranium stocks are simply following the trend in uranium prices.

Lithium (PLS, MIN, LTR)

Pilbarra Minerals (PLS): Medium term share price falling, short positions falling

Mineral Resources (MIN): Medium term share price falling, short positions rising

Liontown Resources (LTR): Medium term share price falling, short positions flat

The same can be said for Lithium (blue line). Mineral Resources has had some other issues which some would like to blame for the fall in share price. That may or may not be the case but it’s clear they have been swimming against they tide of a falling Lithium price.

Most Shorted ASX Stocks 5/2/25 - Lithium spot price and some key ASX lithium stock price charts

Adriatic Metals (ADT)

Medium term share price rising, short positions flat

Silver prices are up, and so is ADT. So why is there a large short position? Without a deep analysis, one possibility is that short-sellers anticipate a capital raise. ADT currently has $59M in cash and $176M in debt, which is concerning given their negative cash flows.

Genesis Minerals (GMD)

Medium term share price rising, short positions falling

Similar to ADT, Genesis Minerals’ share price has been rising, largely in tandem with the gold price. A couple of years ago, the company set ambitious growth plans, which came with significant execution risks, making it an attractive target for short-sellers. However, over time, they have successfully delivered on their strategy. As a result, short positions have steadily declined over the past 12 months.

Most Shorted ASX Stocks 5/2/25 - GMD share price chart and short positions chart for the past 12 months

Karoon Energy (KAR)

Medium term share price falling, short positions rising

Oil prices have been in a downtrend since April 2024, and Karoon’s share price has followed suit, with short positions rising. Textbook shorting strategy.

12 month share price for Karoon Energy KAR

Syrah Resources (SYR)

Medium term share price down, short positions flat

The graphite market has been pressured by increased Chinese synthetic supply. SYR has $81M in cash and $221M in debt, with no cash flows, making it an ideal short-selling candidate.

Lynas Rare Earths (LYC)

Medium term share price flat, short positions flat to down

This one is more complex, but its 9% short position cannot be ignored. The key rare earth element, Neodymium, has remained flat in 2024. LYC also trades at a high price-to-earnings ratio (PER) of 40, which is steep for a cyclical resource company. That valuation is likely what attracts short-sellers.

ASX:LYC 12 month share price chart and short position chart

Dominos Pizza (DMP)

Medium term share price down, short positions up

A fallen angel. Once a market darling, DMP is now struggling to find growth in Australia and its expansion into Japan has been challenging. With $1.4B in debt, it’s easy to see why short-sellers are betting against it.

IDP Education (IEL)

Medium term share price down, short positions flat

Another fallen angel. A former high-flyer, IEL has struggled to find growth in recent years, much to the delight of short-sellers.

The Star Entertainment Group (SGR)

Medium term share price down, short positions up

The well-documented problems at The Star, combined with a significant debt burden, have made it a prime target for short-sellers. The share price chart resembles those of companies that ultimately went bankrupt. Can they turn it around, or will they meet the same fate?

Megaport (MP1)

Medium term share price down, short positions up

Same story as IEL—a former market darling that has been re-rated as growth slowed.

Lifestyle Communities (LIC)

Medium term share price down, short positions up

Yet another high-flyer that has fallen back to earth as growth has slowed.

Johns Ling Group (JLG)

Medium term share price down, short positions up

Another fallen angel that got ahead of itself before being re-rated when growth rates slowed substantially.

Cettire (CTT)

Medium term share price down, short positions up

Similar to JLG, re-rated as growth slowed.

Corporate Travel (CTD)

Medium term share price up, short positions up

After a big fall, CTD shares have been rallying. However, short positions remain high. Valuations are now more realistic, and the balance sheet looks healthy. Will short-sellers be forced to cover, or will CTD disappoint the market?

Droneshield (DRO)

Medium term share price down, short positions up

Balance sheet is safe after two large capital raises at peak prices, but profitability remains uncertain. Their latest cash flow report suggests profitability is still a long way off.

ASX:DRO short positions chart over the last 12 month

Key Observations

  • 11 of the 20 are resource stocks
    • 3 uranium stocks
    • 3 lithium stocks
    • 1 silver stock
    • 1 gold stock
    • 1 oil stock
    • 1 graphite stock
    • 1 rare earths stock
  • 8 of 9 non-resource stocks are fallen angels

Short-Seller Strategy

Target resource stocks when the underlying commodity price is in a downtrend.
Short high P/E companies once growth expectations fail to materialize.
Focus on businesses with high debt, especially those that may need to recapitalize or risk default.

Conclusion Most Shorted ASX Stocks 5/2/25

Taking a long position in the most shorted ASX stocks as of 5/2/25 requires strong conviction. So far, short-sellers have executed their strategy exceptionally well. Genesis Minerals (GMD) stands out as the only major exception, where they may have got it wrong.

Their success rate remains impressive, especially with the ASX near all-time highs. However, nothing lasts forever. At some point, a few of these companies will recover, and when they do, large short positions could fuel a sharp and sustained rally.

 

 


Disclaimer: This information is provided purely for educational purposes. It takes no account of an individual’s personal financial circumstances and hence can in no way constitute financial advice. The above data may be subject to errors or inconsistencies for which the author takes no liability. It is imperative that all investors do their own research or if they need advice, seek it from a qualified financial adviser.

Most Shorted ASX Stocks 5/2/25

ASX Small Ords Seasonality

Date: 30-11-2025 16:42:31 | This table shows the monthly seasonality data for the ASX Small Ords Index (XSO).

XSO Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2025 4.6% -3.0% -4.4% 1.8% 5.5% 0.9% 2.8% 8.8% 2.2% 0.2% 19.4%
2024 0.7% 1.5% 4.1% -3.1% -0.1% -2.2% 4.1% -2.8% 5.0% 0.7% 1.4% -3.4% 5.7%
2023 7.5% -3.9% -1.4% 2.8% -3.5% -0.3% 3.5% -1.6% -4.9% -5.4% 6.9% 7.2% 6.9%
2022 -9.0% -0.2% 4.6% -3.5% -5.3% -13.4% 10.6% 1.0% -11.8% 6.3% 4.8% -4.8% -20.7%
2021 0.2% 1.8% -0.6% 4.9% 0.2% 2.8% 1.7% 3.7% -2.7% 1.8% -1.3% 1.1% 13.6%
2020 3.4% -9.6% -22.2% 14.3% 11.0% -2.6% 1.3% 7.1% -3.3% -0.2% 10.8% 2.5% 12.3%
2019 5.6% 6.5% -0.2% 3.4% -1.3% 1.1% 4.0% -4.1% 1.9% -0.7% 1.6% -0.8% 17.1%
2018 -0.4% -0.4% -4.4% 4.6% 3.7% 0.4% -0.7% 2.2% -1.1% -9.5% -0.4% -4.5% -10.6%
2017 -1.9% 1.1% 1.8% -0.4% -2.1% 1.6% 0.3% 2.5% 1.4% 5.0% 3.8% 2.9% 16.0%
2016 -4.4% 0.0% 4.5% 4.1% 2.8% -1.6% 9.6% -2.7% 0.6% -4.8% -1.2% 2.7% 9.5%
2015 1.2% 7.9% -2.9% 1.6% 1.5% -7.4% 1.5% -5.1% -1.6% 6.4% 0.6% 3.6% 7.3%
2014 -2.8% 4.7% -1.9% -1.3% 0.8% -2.1% 4.8% 2.1% -6.3% -0.7% -7.5% 4.1% -6.1%
2013 4.2% 0.6% -4.1% -4.6% -3.9% -8.5% 11.0% 4.1% -0.6% 2.7% -6.3% 3.3% -2.2%
2012 6.1% 5.1% 0.8% -1.2% -10.3% -4.2% -1.1% 2.5% 3.2% 1.4% -2.5% 3.0% 2.8%
2011 -2.2% 1.0% -0.7% -3.5% -1.2% -5.3% 3.3% -4.9% -11.2% 7.8% -3.8% -3.1% -23.9%
2010 -10.2% 3.7% 4.9% 0.0% -8.3% -4.0% 6.7% 0.0% 8.4% 4.4% -0.7% 6.8% 11.7%
2009 -7.2% -8.4% 11.0% 13.5% 9.8% 0.2% 9.0% 6.1% 4.5% -3.7% 4.1% 4.0% 42.9%
2008 -14.5% 3.6% -5.4% 3.4% 3.3% -11.4% -5.5% 1.8% -16.0% -24.9% -10.6% 6.8% -69.4%
Average -1.4% 0.9% -0.7% 2.1% -0.2% -3.4% 3.8% 0.7% -2.0% -0.8% 0.0% 1.8% 0.8%
Positive 8 12 7 9 8 5 14 11 7 9 8 12 11
Negative 9 5 10 8 9 12 3 6 10 8 9 5 6
Since 2009
Average -0.6% 0.7% -0.4% 2.0% -0.4% -2.8% 4.4% 0.6% -1.2% 0.7% 0.6% 1.5% 5.1%
Positive 8 11 6 7 6 4 13 9 6 9 7 10 10
Negative 7 4 9 8 9 11 2 6 9 6 8 5 5

Small Ordinaries XSO 12 Month Price Chart

Small Ordinaries XSO 12 Month Price Chart

Cutting Through The Noise: ASX:S32

Sector: Basic Materials | Industry: Other Industrial Metals & Mining | Website: https://www.south32.net

Commodity Analysis

Profits for S32 were generated from the following commodities in 2024:

Cutting Through The Noise: ASX:S32 - EBITDA mix FY24 for ASX:S32

In their latest quarterly result, S32 received higher prices for most of their commodities:

Latest quarterly realised prices for ASX:S32

In January trends have remained overall favourable:

Aluminium – having a very strong start to the year

Cutting Through The Noise: ASX:S32 - Aluminium futures 1 year chart with 4 EMAs and volume

Copper – also a strong start to the year, despite the falls of the last two days.

ASX:S32 Copper futures 1 year price chart with volume and 4 EMAs

Silver

ASX:S32 Silver futures 1 year price chart with volume and 4 EMAs

Zinc – a lot of these charts look similar, bouncing to start the year.

ASX:S32 Zinc futures 1 year price chart with volume and 4 EMAs

Lead – while the chart is ugly, it’s up for January

ASX:S32 Lead futures 1 year price chart

Manganese – like lead, ugly chart but up to start the year

ASX:S32 Manganese futures 1 year price chart

Coal – the one drag at present

ASX:S32 Coal futures 1 year price chart

Broker Positioning

Market forecasts are for a return to growth in 2025 and 2026. These numbers can change quickly though. If the moves in the commodities as shown above continue, analysts will need to update their numbers which could see some upgrades come through.

Cutting Through The Noise: ASX:S32 - EPS history chart with forecasts for 25,26,27 and 2028 vs share price

Valuation Model

Valuation is a tricky game with highly cyclical companies like S32. Nevertheless, my model suggest there is some value at present in S32 with a reasonable margin of safety.

Cutting Through The Noise: ASX:S32 - Valuation model chart

Technical Analysis

Cutting Through The Noise: ASX:S32 - 12 month price chart with 3EMA and volume

The price chart shows a decline from recent highs throughout November on lower than normal volume. This is consistent with the fall in many of their commodities during the same period. Prices have started to move higher in January and the commodity charts above support this. The 3EMA have not crossed as yet but look poised to do so. The only ingredient missing so far is an increase in volume.

ASX:S32 short positions over the past 12 months

Short positions have been falling since the middle of last-year. This perhaps suggests that the short-sellers believe the worst is over for S32.

Final Word

S32’s performance in early 2024 has been influenced by favourable trends across most of its key commodities, with aluminium and copper leading the way, while coal remains a drag. Market forecasts anticipate a return to growth in the coming years, though these projections are subject to change based on commodity price movements. From a valuation perspective, the company appears to offer some margin of safety despite the cyclical nature of its business. Technically, the stock has shown early signs of recovery in January, though a confirmed upward trend may require stronger volume. Additionally, the decline in short positions since mid-2023 suggests improving sentiment among investors.


Disclaimer: This information is provided purely for educational purposes. It takes no account of an individual’s personal financial circumstances and hence can in no way constitute financial advice. The above data may be subject to errors or inconsistencies for which the author takes no liability. It is imperative that all investors do their own research or if they need advice, seek it from a qualified financial adviser.

Cutting Through The Noise: ASX:S32

Rule Of 40 Stocks

Date: 30-11-2025 20:06:28 | This table shows stocks filtered by the Rule of 40 criteria, a metric which aims to balance growth and profitability to assess business health. | Utilities, Property and Resource companies have been omitted. | Learn more about the Rule of 40 HERE.

1-Week Statistics

  • Average 1w return: 0.52%
  • Median 1w return: -0.83%
  • Winners: 38
  • Losers: 42

6-Month Statistics

  • Average 6m return: 35.06%
  • Median 6m return: 20.70%
  • Winners: 64
  • Losers: 16

12-Month Statistics

  • Average 12m return: 32.64%
  • Median 12m return: 16.87%
  • Winners: 59
  • Losers: 20

# Rule of 40 Name Ticker 1 Month 6 Months 12 Months
1 247.2% DroneShield Limited DRO -36.74% 125.00% 50.00%
2 231.9% Pinnacle Investment Management Group Limited PNI -4.20% 18.11% 1.44%
3 223.6% Omni Bridgeway Limited OBL -10.00% 12.50% 44.50%
4 172.0% NVIDIA Corporation NVDA 3.74% 87.68% 44.08%
5 113.5% WHSP Holdings Limited SOL -10.84% 9.94% 7.23%
6 110.1% Generation Development Group Limited GDG 9.82% 51.38% 128.37%
7 106.3% Pro Medicus Limited PME -10.06% 40.45% 48.89%
8 100.9% Helia Group Limited HLI -1.40% 39.16% 39.85%
9 96.5% SKS Technologies Group Limited SKS 41.64% 164.33% 196.43%
10 87.1% Micron Technology, Inc. MU 99.19% 265.39% 132.25%
11 83.8% GQG Partners Inc. GQG 4.52% -2.12% -28.29%
12 80.2% Auckland International Airport Limited AIA 2.64% -3.97% 4.63%
13 75.9% Netwealth Group Limited NWL -6.39% 27.14% 15.10%
14 73.2% Challenger Limited CGF 6.86% 60.29% 33.94%
15 71.5% Tuas Limited TUA -14.51% 27.56% 20.67%
16 71.4% Chorus Limited CNU -9.03% 8.77% 0.50%
17 70.1% REA Group Limited REA -17.98% -12.37% -8.13%
18 68.5% Sigma Healthcare Limited SIG -4.95% -0.35% 41.18%
19 67.5% ASX Limited ASX -5.06% -8.30% -8.83%
20 66.8% Smart Parking Limited SPZ 45.83% 97.18% 129.51%
21 66.8% Telix Pharmaceuticals Limited TLX 10.53% -35.59% -25.68%
22 65.6% Clinuvel Pharmaceuticals Limited CUV 12.58% 12.90% -15.54%
23 63.9% AUB Group Limited AUB 4.87% 24.58% 21.41%
24 61.5% Palantir Technologies Inc. PLTR 8.75% 127.60% 329.28%
25 60.4% HUB24 Limited HUB 0.88% 75.97% 73.18%
26 60.2% Reef Casino Trust RCT -6.65% -0.85% 24.47%
27 60.0% Commonwealth Bank of Australia CBA -9.22% -0.97% 14.89%
28 59.6% Vysarn Limited VYS 14.55% 53.66% 31.25%
29 59.5% Technology One Limited TNE -20.01% 18.74% 24.12%
30 59.3% CAR Group Limited CAR -11.07% 12.38% -6.38%
31 58.5% WiseTech Global Limited WTC -23.02% -2.42% -44.06%
32 55.4% Nu Holdings Ltd. NU 16.71% 81.15% 32.75%
33 55.2% oOh!media Limited OML -22.26% -10.84% 0.39%
34 55.0% Upstart Holdings, Inc. UPST -30.25% 29.20% 15.46%
35 54.8% Praemium Limited PPS 9.49% 29.10% 51.75%
36 54.4% Judo Capital Holdings Limited JDO -4.19% -3.03% -2.44%
37 54.3% Acrow Limited ACF 4.37% 4.37% 2.38%
38 54.1% Atlas Arteria Limited ALX -4.23% 1.63% 3.97%
39 54.0% ANZ Group Holdings Limited ANZ 4.34% 22.92% 16.87%
40 54.0% Integral Diagnostics Limited IDX -7.37% 15.79% -13.44%
41 53.6% Alphabet Inc. GOOGL 38.81% 119.90% 93.04%
42 53.3% Tasmea Limited TEA 8.13% 97.12% 109.17%
43 52.9% Microsoft Corporation MSFT -2.64% 36.73% 18.12%
44 52.9% Xero Limited XRO -22.13% -16.00% -15.88%
45 52.4% Southern Cross Electrical Engineering Limited SXE 25.79% 44.85% 38.15%
46 51.7% Transurban Group TCL 3.68% 9.06% 13.97%
47 51.2% Reckon Limited RKN -0.85% 21.87% 14.71%
48 50.1% Cogstate Limited CGS 44.13% 85.61% 183.52%
49 50.0% Light & Wonder, Inc. LNW 16.68% 15.04% 8.75%
50 49.1% Codan Limited CDA 3.38% 110.72% 97.76%
51 48.0% Westpac Banking Corporation WBC -0.82% 21.30% 24.72%
52 47.7% Alliance Aviation Services Limited AQZ -41.10% -44.84% -51.57%
53 47.5% Kina Securities Limited KSL -5.73% 10.27% 22.28%
54 47.0% Kelly Partners Group Holdings Limited KPG -19.16% -14.80% 12.42%
55 46.7% Credit Corp Group Limited CCP -15.50% 13.65% -11.58%
56 46.1% Cobram Estate Olives Limited CBO -5.49% 67.57% 76.14%
57 46.0% Chrysos Corporation Limited C79 21.99% 110.39% 46.21%
58 45.7% MA Financial Group Limited MAF 6.98% 55.31% 74.05%
59 45.5% IPH Limited IPH -19.82% -20.90% -38.14%
60 45.2% Megaport Limited MP1 1.85% 55.94% 94.29%
61 45.0% Smartgroup Corporation Ltd SIQ -3.19% 20.25% 6.67%
62 44.9% Aurizon Holdings Limited AZJ 11.87% 15.86% 1.99%
63 44.5% GenusPlus Group Ltd GNP 27.84% 146.04% 162.90%
64 44.4% Magellan Financial Group Limited MFG -7.85% 34.51% -1.14%
65 44.3% Lovisa Holdings Limited LOV -21.19% 40.61% -7.35%
66 43.9% Universal Store Holdings Limited UNI 3.97% 20.00% 13.68%
67 43.5% ResMed Inc. RMD -5.21% 16.10% 13.42%
68 43.3% SEEK Limited SEK -8.49% 20.12% -1.84%
69 43.0% Infomedia Ltd IFM 0.30% 35.60% 14.53%
70 42.9% MyState Limited MYS 3.49% 19.30% 22.59%
71 42.8% Objective Corporation Limited OCL -12.88% 21.15% 18.19%
72 42.8% Australian Ethical Investment Limited AEF -19.80% 2.15% 32.18%
73 42.6% Guzman y Gomez (Holdings) Ltd GYG 0.04% -23.81% -37.97%
74 42.3% Cuscal Limited CCL 6.68% 66.95%
75 41.9% NEXTDC Limited NXT -15.56% 27.42% -23.59%
76 41.8% Bendigo and Adelaide Bank Limited BEN -18.79% 0.79% -10.33%
77 41.8% Dalrymple Bay Infrastructure Limited DBI 3.92% 17.75% 37.08%
78 41.7% ALS Limited ALQ 20.70% 47.30% 53.58%
79 41.5% Superloop Limited SLC 0.00% 31.92% 64.33%
80 41.0% ReadyTech Holdings Limited RDY 5.75% 1.70% -18.15%

NASDAQ Seasonality

Date: 01-12-2025 08:31:04 | This table shows the monthly seasonality data for the US NASDAQ index.

NASDAQ Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2025 1.6% -4.0% -8.2% 0.9% 10.3% 5.9% 3.7% 0.7% 6.5% 3.1% 20.5%
2024 2.7% 6.1% 1.9% -4.5% 6.9% 6.8% -1.6% -2.6% 6.1% -0.5% 7.2% -0.5% 28.1%
2023 11.5% -1.1% 6.7% -0.1% 5.9% 6.6% 4.0% -2.2% -5.2% -3.4% 10.7% 3.8% 37.3%
2022 -9.0% -3.4% 3.4% -11.8% -3.6% -8.7% 12.2% -4.5% -10.5% 3.9% 4.4% -9.4% -37.2%
2021 4.0% 1.4% -2.5% 5.4% -1.6% 5.6% 1.2% 3.9% -5.3% 7.9% -0.4% 0.7% 20.3%
2020 2.0% -2.2% -14.0% 15.4% 7.5% 5.3% 6.8% 9.6% -5.2% -1.9% 11.3% 5.7% 40.4%
2019 9.7% 3.4% 3.9% 3.4% -7.9% 8.6% 1.0% -3.7% 1.6% 3.7% 3.3% 4.7% 31.8%
2018 -0.4% -0.4% -4.4% 4.6% 5.3% 1.7% 1.4% 5.7% -0.9% -9.1% 0.3% -9.5% -5.7%
2017 3.4% 3.8% 1.5% 3.0% 1.8% -0.9% 3.4% 1.3% 1.4% 3.2% 2.2% 0.4% 24.3%
2016 -7.7% -1.4% 6.8% -1.1% 2.7% -2.1% 7.1% 0.6% 1.9% -2.3% 2.6% 2.0% 9.1%
2015 -1.3% 7.1% -2.1% 0.8% 2.9% -1.9% 2.8% -6.9% -3.3% 11.0% -0.4% -2.0% 6.8%
2014 -1.7% 5.0% -2.5% -2.0% 3.0% 4.0% -0.9% 4.8% -1.9% 3.1% 2.1% 0.2% 13.1%
2013 4.1% 0.6% 2.5% 2.8% 3.8% -0.6% 5.6% -0.2% 4.2% 3.9% 3.2% 3.2% 33.1%
2012 7.7% 6.1% 4.5% -2.4% -7.2% 4.4% -0.4% 4.3% 1.5% -4.4% 1.1% 0.3% 15.6%
2011 1.8% 3.0% 0.0% 3.0% -1.0% -2.2% -1.0% -6.0% -6.4% 11.1% -2.4% -0.3% -0.3%
2010 -4.3% 4.7% 5.5% 2.6% -8.3% -6.5% 8.8% -7.9% 12.0% 5.8% -0.3% 6.2% 18.3%
2009 -5.2% -11.5% 15.6% 12.3% 6.5% 0.3% 7.8% 1.5% 5.6% -3.4% 4.7% 5.8% 40.0%
2008 -9.9% -2.4% -2.3% 5.9% 3.3% -8.0% 1.4% 1.8% -12.0% -17.4% -18.8% 12.8% -45.6%
2007 2.0% -1.9% 0.3% 4.2% 3.1% 1.1% -3.3% 2.0% 5.6% 4.3% -6.9% -0.3% 10.1%
2006 4.0% -1.1% 2.6% -1.5% -5.5% -0.3% -3.7% 4.4% 2.5% 5.8% 2.7% -0.7% 9.2%
2005 -5.2% -0.5% -2.6% -3.5% 7.2% -0.5% 6.7% -2.0% 0.0% -1.5% 5.3% -0.7% 2.8%
2004 3.0% -0.3% -3.1% -3.7% 3.5% 3.1% -7.6% -2.9% 3.2% 4.4% 5.9% 3.7% 9.2%
2003 -1.1% 1.3% 0.3% 9.2% 8.6% 2.0% 6.9% 4.3% -1.3% 8.1% 3.0% 0.7% 42.0%
2002 -0.8% -10.5% 7.6% -9.4% -4.3% -13.1% -5.4% 0.6% -12.3% 13.5% 11.7% -10.1% -32.5%
2001 12.2% -22.4% -17.1% 18.7% -0.3% 1.8% -5.7% -10.9% -18.0% 14.2% 14.2% 1.0% -12.2%
2000 16.2% -0.1% -13.4% -14.1% 16.6% -5.0% 11.7% -15.2% -5.6% -22.9% -4.9% -36.7%
Average 0.9% 0.0% 0.5% 1.5% 0.7% 0.9% 1.7% 0.3% -2.1% 2.2% 1.8% 0.5% 8.9%
Positive 13 12 14 14 15 14 15 14 11 15 18 15 18
Negative 11 13 11 11 10 11 10 11 14 10 7 10 7
Since 2009
Average 1.1% 1.3% 1.7% 2.0% 1.0% 1.3% 3.6% -0.1% -0.3% 1.8% 3.1% 0.7% 17.2%
Positive 9 10 9 9 9 8 11 7 7 9 11 10 12
Negative 6 5 6 6 6 7 4 8 8 6 4 5 3

NASDAQ 12 Month Price Chart

NASDAQ 12 Month Price Chart

US 10 Year Bond Yield

US 10 Year Bond Yield - 12 month daily chart with volume and three exponential moving averages to help quickly determine the trend.

The US 10-Year Treasury Yield represents the annualized return on investment for holding a 10-year U.S. government bond to maturity. It is a key indicator of investor sentiment, economic expectations, and interest rate trends. Often referred to as the “benchmark” yield, it influences a wide range of financial products, including mortgage rates, corporate borrowing costs, and other bond yields. Movements in the 10-year yield are driven by factors such as inflation expectations, Federal Reserve policies, economic growth data, and global market dynamics. A rising yield typically signals higher expectations for inflation and economic growth, while a falling yield may reflect increased demand for safe-haven assets or concerns about economic weakness.


US 10 Year Bond Yield

US Russell 2000 Index

US Russell 2000 Index - 12 month daily chart with volume and three exponential moving averages to help quickly determine the trend.

The Russell 2000 Index is a widely followed stock market index that measures the performance of approximately 2,000 small-cap companies in the United States. It represents the smallest segment of the broader Russell 3000 Index, which includes the largest 3,000 publicly traded U.S. companies. As a key benchmark for small-cap stocks, the Russell 2000 is valued for its focus on smaller, growth-oriented companies that are often domestically focused and less internationally diversified than their larger counterparts. The index is market capitalization-weighted and is frequently used by investors to gauge the performance of the small-cap sector and broader trends in the U.S. economy.


US Russell 2000 Index